Navigation Links
Cytel's Clinical Innovation Experts Cyrus Mehta and Judith Quinlan Reveal Latest Adaptive Trial Successes at 44th Annual DIA Meeting
Date:6/23/2008

Trial design and implementation pioneers from Cytel join peers in examining

the rise of adaptive study approaches and overcoming the remaining

challenges to wider adoption

CAMBRIDGE, Mass., June 23 /PRNewswire/ -- Cytel's renowned adaptive trial design and implementation experts Cyrus Mehta (http://www.cytel.com) and Judith Quinlan (http://www.cytel.com) will lead workshops and case study reviews at the Annual Meeting of the Drug Information Association (DIA) June 22 - 25, 2008 in Boston.

Adaptive trials are finding ever-increasing acceptance by sponsors and regulators seeking to improve clinical development productivity and reduce the rate of trial failures. Combining a wealth of experience designing and implementing adaptive trials together with over 20 years developing software for trial design, simulation and analysis, Cytel's clinical innovation know- how is unmatched.

At this year's DIA meeting, senior managers, clinicians, statisticians and trial logistics professionals from the biopharmaceutical industry will share their recent experiences with adaptive trials, and the insights gained on planning and conducting the next generation of adaptive studies.

Speaking on the latest innovative trial techniques and tools will be Cytel Co-Founder and President, Dr. Cyrus Mehta, and Vice President of Adaptive Trials, Judith Quinlan.

Dr. Mehta will join Dr. William Byrom, Vice President, Product Strategy at trial technology leader ClinPhone, for the workshop "Adaptive Design in Clinical Research", June 23, 10:30A - 12:30P.

Reporting on the PhRMA Working Group for Adaptive Trials efforts to chronicle trial innovation successes, Cytel's Judith Quinlan presents "Are You Ready for Adaptive Clinical Development? Examples, Case Studies, Successes" on June 24, 8:30A - 9:30A.
See the complete DIA meeting website

http://www.diahome.org/DIAHome/FlagshipMeetings/home.aspx?meetingid=14235

and the DIA's blog site

http://www.diaannual.com/

Dr. Mehta and Vice President Quinlan are available for interviews following the DIA conference.


'/>"/>
SOURCE Cytel, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
4. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
5. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
6. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
7. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
8. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
9. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
10. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
11. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/10/2017)... -- NDS received FDA 510(k) clearance in May 2017 for its highly ... designed for endoscopy environments. An innovative secondary monitor solution, ZeroWire ... support the improvement of patient outcomes, procedural efficiency, and the lowering ... ... ...
(Date:10/4/2017)... 4, 2017  South Korean-based healthcare product Development Company ... "cprCUBE" on Kickstarter. The device will educate the user ... with better efficiency compared to the dated and pricey ... on efficacy of the compression for a more informed ... goal to raise $5,000. ...
(Date:10/2/2017)... 2017  Eli Lilly and Company (NYSE: ... third quarter of 2017 on Tuesday, October 24, 2017. ... day with the investment community and media to further ... call will begin at 9 a.m. Eastern time. Investors, ... webcast of the conference call through a link that ...
Breaking Medicine Technology:
(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Apple ... care services, staged a mock evacuation of the facility as part of a disaster ... Fire Department, Echo Hose EMS and Shelton City Emergency Manager, as well as the ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Global Healthcare Management’s ... Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare Management’s ... The fun run is geared towards children of all ages; it is a ...
(Date:10/13/2017)... ... October 13, 2017 , ... “The Journey: From the ... danger possible to save lost souls in the Philippines. “The Journey: From the Mountains ... a dedicated teacher of the Bible. She has taught all ages and currently teaches ...
(Date:10/12/2017)... ... October 12, 2017 , ... Planet Fitness, one of the largest and ... plans to open a flagship location in Covington, LA at 401 N. U.S. Highway ... store next to Office Depot in the Holiday Square shopping center. Its location allows ...
(Date:10/12/2017)... ... 2017 , ... Asante, a nationally recognized health system in ... existing home health joint venture through an agreement, effective October 1, 2017, to ... home health company with Asante, delivering clinically integrated care, for the past eight ...
Breaking Medicine News(10 mins):